Host Genetic Control of Mouse Hepatitis Virus Type 4 (JHM Strain) Replication. I. Restriction of Virus Amplification and Spread in Macrophages from Resistant Mice

References

1. Arnheiter H., Haller O. 1981; Inborn resistance of mice to mouse hepatitis virus type 3 (MHV3): liver parenchymal cells express phenotype in culture. Advances in Experimental Medicine and Biology 142:409–417
   [Google Scholar]
2. Bailey O. T., Pappenheimer A. M., Cheever F. S., Daniels J. B. 1949; A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. II. Pathology. Journal of Experimental Medicine 90:195–212
   [Google Scholar]
3. Bang F. B. 1981; The use of genetically incompatible combination of host and virus (MHV) for the study of mechanisms of host resistance. In Advances in Experimental Medicine and Biology 142:359–373
   [Google Scholar]
4. Bang F. B., Warwick A. 1960; Mouse macrophages as host cells for the mouse hepatitis virus and the genetic basis of their susceptibility. Proceedings of the National Academy of Sciences, U. S. A 46:1065–1075
   [Google Scholar]
5. Booss J. 1980; Establishment of cytomegalovirus infection in mice: role of a macrophage-enriched sub population. Journal of Infectious Diseases 141:466–472
   [Google Scholar]
6. Brautigam A. R., Dutko F. J., Olding L. B., Oldstone M. B. A. 1979; Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. Journal of General Virology 44:349–359
   [Google Scholar]
7. Brinton M. A., Nathanson N. 1981; Genetic determinants of virus susceptibility: epidemiologic implications of murine models. Epidemiologic Reviews 3:115–139
   [Google Scholar]
8. Brinton M. A., Blank K. J., Nathanson N. 1983; Host genes which influence susceptibility to viral diseases. In Concepts in Viral Pathogenesis (in press) Edited by Notkins A. L., Oldstone M. B. A. New York: Springer-Verlag;
   [Google Scholar]
9. Casali P., Sissons J. G. P., Buchmeier M. J., Oldstone M. B. A. 1981; In vitro generation of human cytotoxic lymphocytes by virus: viral glycoproteins induce nonspecific cell-mediated cytotoxicity without release of interferon. Journal of Experimental Medicine 154:840–855
   [Google Scholar]
10. Collins A. R., Knobler R. L., Powell H., Buchmeier M. J. 1982; Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology 119:358–371
    [Google Scholar]
11. Collins A. R., Tunison L. A., Knobler R. L. 1983; Mouse hepatitis virus type 4 infection of primary glial cultures from genetically susceptible and resistant mice. Infection and Immunity 40:1192–1197
    [Google Scholar]
12. De Maeyer E., De Maeyer-Guignard J. 1979; Interferons. In Comprehensive Virology vol 15: pp 205–284 Edited by Fraenkel-Conrat H., Wagner R. R. New York: Plenum Press;
    [Google Scholar]
13. Haller O., Arnheiter H., Gresser I., Lindenmann J. 1981; Virus-specific interferon action: protection of newborn Mx carriers against lethal infection with influenza virus. Journal of Experimental Medicine 154:199–203
    [Google Scholar]
14. Haspel M. V., Lampert P. W., Oldstone M. B. A. 1978; Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proceedings of the National Academy of Sciences, U. S. A 75:4033–4036
    [Google Scholar]
15. Knobler R. L., Haspel M. V., Oldstone M. B. A. 1981; Mouse hepatitis virus type-4 (JHM strain)-induced fatal central nervous system disease. I. Genetic control and the murine neuron as the susceptible site of disease. Journal of Experimental Medicine 153:832–843
    [Google Scholar]
16. Knobler R. L., Lampert P. W., Oldstone M. B. A. 1982; Virus persistence and recurrent demyelination produced by a temperature-sensitive mutant of mouse hepatitis virus. Nature, London 298:278–280
    [Google Scholar]
17. Lampert P. W., Sims J. K., Kniazeff A. J. 1973; Mechanism of demyelination in JHM virus encephalomyelitis. Acta neuropathologica 24:76–85
    [Google Scholar]
18. Lee K. C. 1980; On the origin and mode of action of functionally distinct macrophage subpopulations. Molecular and Cellular Biochemistry 30:39–55
    [Google Scholar]
19. Merigan T. C., Finkelstein M. S. 1968; Interferon-stimulating and in vivo antiviral effects of various synthetic anionic polymers. Virology 35:363–374
    [Google Scholar]
20. Miller G. A., Morahan P. S., White S., Jessee E. 1982; Functional and biochemical heterogeneity among subpopulations of rat and mouse peritoneal macrophages. Journal of the Reticuloendothelial Society 32:111–124
    [Google Scholar]
21. Schindler L., Engler H., Kirchner H. 1982; Activation of natural killer cells and induction of interferon after injection of mouse hepatitis virus type 3 in mice. Interferon and Immunity 35:869–873
    [Google Scholar]
22. Sorensen O., Dugre R., Percy D., Dales S. 1982; In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice. Infection and Immunity 37:1248–1260
    [Google Scholar]
23. Stohlman S. A., Frelinger J. A. 1978; Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM. I. Genetic analysis. Immunogenetics 6:271–281
    [Google Scholar]
24. Stohlman S. A., Frelinger J. A. 1981; Macrophages and resistance to JHM virus CNS infection. Advances in Experimental Medicine and Biology 142:387–398
    [Google Scholar]
25. Stohlman S. A., Sakaguchi A. Y., Hiti A. 1978; Interferon production and activity in mouse neuroblastoma cells. Archives of Virology 57:91–96
    [Google Scholar]
26. Sturman L. S., Holmes K. V. 1984; Proteolytic cleavage of peplomeric glycoprotein E2 of MHV yields two 90K subunits and activates cell fusion. Advances in Experimental Medicine and Biology (in press)
    [Google Scholar]
27. Ter Meulen V., Siddell S., Wege H. (editors) 1981; Biochemistry and biology of coronaviruses. Advances in Experimental Medicine and Biology 142:1–438
    [Google Scholar]
28. Van Furth R., Van Zwet T. L., Leijh P. C. J. 1978; In vitro determination of phagocytosis and intracellular killing by polymorphonuclear and mononuclear phagocytes. In Handbook of Experimental Immunology vol 2: pp 32.1–32.19 Edited by Weir D. M. Oxford: Blackwell Scientific Publications;
    [Google Scholar]
29. Virelizier J. L. 1981; Role of macrophages and interferon in natural resistance to mouse hepatitis virus infection. In Current Topics in Microbiology and Immunology vol 92: pp 53–64 Edited by Haller O. Berlin: Springer-Verlag;
    [Google Scholar]
30. Virelizier J. L., Allison A. C. 1976; Correlation of persistent mouse hepatitis (MHV-3) infection with its effects on mouse macrophage cultures. Archives of Virology 50:279–285
    [Google Scholar]
31. Virelizier J. L., Allison A. C., De Maeyer E. 1977; Production by mixed lymphocyte cultures of a type II interferon able to protect macrophages against virus infections. Infection and Immunity 17:282–285
    [Google Scholar]
32. Waksman B. H., Adams R. D. 1982; Infectious leukoencephalitis: a critical comparison of certain experimental and naturally-occurring viral leukoencephalitides with experimental allergic encephalomyelitis. Journal of Neuropathology and Experimental Neurology 21:491–518
    [Google Scholar]
33. Weiner L. P. 1973; Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus). Archives of Neurology 28:298–303
    [Google Scholar]